Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular subtypes of clear cell carcinoma of the endometrium: Opportunities for prognostic and predictive stratification
Soyoun Rachel Kim, Basile Tessier Cloutier, Samuel Leung, et al.
Gynecologic Oncology (2020) Vol. 158, Iss. 1, pp. 3-11
Closed Access | Times Cited: 98

Showing 1-25 of 98 citing articles:

Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Ana Oaknin, Tjalling Bosse, Carien L. Creutzberg, et al.
Annals of Oncology (2022) Vol. 33, Iss. 9, pp. 860-877
Open Access | Times Cited: 387
New Pathological and Clinical Insights in Endometrial Cancer in View of the Updated ESGO/ESTRO/ESP Guidelines
Angela Santoro, Giuseppe Angelico, Antonio Travaglino, et al.
Cancers (2021) Vol. 13, Iss. 11, pp. 2623-2623
Open Access | Times Cited: 133
Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry
Lisa Vermij, Jan J. Jobsen, Alicia León‐Castillo, et al.
British Journal of Cancer (2023) Vol. 128, Iss. 7, pp. 1360-1368
Open Access | Times Cited: 87
Prognostic relevance of the molecular classification in high-grade endometrial cancer for patients staged by lymphadenectomy and without adjuvant treatment
Alicia León‐Castillo, Nanda Horeweg, Elke E.M. Peters, et al.
Gynecologic Oncology (2022) Vol. 164, Iss. 3, pp. 577-586
Open Access | Times Cited: 76
Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death
Amy Jamieson, Jutta Huvila, Derek S. Chiu, et al.
Modern Pathology (2023) Vol. 36, Iss. 4, pp. 100085-100085
Open Access | Times Cited: 53
Mismatch Repair Deficiency as a Predictive and Prognostic Biomarker in Endometrial Cancer: A Review on Immunohistochemistry Staining Patterns and Clinical Implications
Francesca Addante, Antonio d’Amati, Angela Santoro, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1056-1056
Open Access | Times Cited: 17
Endometrial carcinoma: molecular subtypes, precursors and the role of pathology in early diagnosis
Jutta Huvila, Jennifer Pors, Emily F. Thompson, et al.
The Journal of Pathology (2020) Vol. 253, Iss. 4, pp. 355-365
Open Access | Times Cited: 113
Clinicopathologic and Genomic Analysis of TP53-Mutated Endometrial Carcinomas
Amir Momeni Boroujeni, Wissam Dahoud, Chad Vanderbilt, et al.
Clinical Cancer Research (2021) Vol. 27, Iss. 9, pp. 2613-2623
Open Access | Times Cited: 74
p53abn Endometrial Cancer: understanding the most aggressive endometrial cancers in the era of molecular classification
Amy Jamieson, Emily F. Thompson, Jutta Huvila, et al.
International Journal of Gynecological Cancer (2021) Vol. 31, Iss. 6, pp. 907-913
Closed Access | Times Cited: 72
The emerging role of molecular pathology in directing the systemic treatment of endometrial cancer
Amy Jamieson, Tjalling Bosse, Jessica N. McAlpine
Therapeutic Advances in Medical Oncology (2021) Vol. 13
Open Access | Times Cited: 72
Current and Emerging Prognostic Biomarkers in Endometrial Cancer
Kelechi Njoku, Chloe E. Barr, Emma J. Crosbie
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 58
Radiation Therapy for Endometrial Cancer: An American Society for Radiation Oncology Clinical Practice Guideline
Matthew M. Harkenrider, Nadeem R. Abu‐Rustum, Kevin Albuquerque, et al.
Practical Radiation Oncology (2022) Vol. 13, Iss. 1, pp. 41-65
Closed Access | Times Cited: 54
Endometrial carcinoma molecular subtype correlates with the presence of lymph node metastases
Amy Jamieson, Emily F. Thompson, Jutta Huvila, et al.
Gynecologic Oncology (2022) Vol. 165, Iss. 2, pp. 376-384
Closed Access | Times Cited: 44
Molecular subtypes of endometrial cancer: Implications for adjuvant treatment strategies
Ye Yang, Su Fang Wu, Wei Bao
International Journal of Gynecology & Obstetrics (2023) Vol. 164, Iss. 2, pp. 436-459
Open Access | Times Cited: 38
Molecular Profiling of Endometrial Cancer From TCGA to Clinical Practice
Amy Jamieson, Jessica N. McAlpine
Journal of the National Comprehensive Cancer Network (2023) Vol. 21, Iss. 2, pp. 210-216
Closed Access | Times Cited: 37
Molecular Classification of Endometrial Cancer and the 2023 FIGO Staging: Exploring the Challenges and Opportunities for Pathologists
Wenxin Zheng
Cancers (2023) Vol. 15, Iss. 16, pp. 4101-4101
Open Access | Times Cited: 32
Molecular subtype stratified outcomes according to adjuvant therapy in endometrial cancer
Amy Jamieson, Jutta Huvila, Samuel Leung, et al.
Gynecologic Oncology (2023) Vol. 170, pp. 282-289
Closed Access | Times Cited: 23
Comprehensive Review of Endometrial Cancer: New Molecular and FIGO Classification and Recent Treatment Changes
Maria-Bianca Anca-Stanciu, Andrei Manu, Maria Olincă, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1385-1385
Open Access | Times Cited: 1
Clear cell carcinoma of the endometrium
Giorgio Bogani, Isabelle Ray‐Coquard, Nicole Concin, et al.
Gynecologic Oncology (2022) Vol. 164, Iss. 3, pp. 658-666
Open Access | Times Cited: 35
Prognostic significance of CTNNB1 mutation in early stage endometrial carcinoma: a systematic review and meta-analysis
Antonio Travaglino, Antonio Raffone, Diego Raimondo, et al.
Archives of Gynecology and Obstetrics (2022) Vol. 306, Iss. 2, pp. 423-431
Open Access | Times Cited: 29
Clinicopathological characteristics of multiple-classifier endometrial cancers: a cohort study and systematic review
Luigi Antonio De Vitis, Gabriella Schivardi, Giuseppe Caruso, et al.
International Journal of Gynecological Cancer (2023) Vol. 34, Iss. 2, pp. 229-238
Open Access | Times Cited: 21
Update in the molecular classification of endometrial carcinoma
Alicia León‐Castillo
International Journal of Gynecological Cancer (2023) Vol. 33, Iss. 3, pp. 333-342
Open Access | Times Cited: 20
Targeting the immune microenvironment for ovarian cancer therapy
Félix Blanc‐Durand, Lai Clemence Wei Xian, David S.P. Tan
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 19
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with endometrial cancer
Smruti Koppikar, Ana Oaknin, K. Govind Babu, et al.
ESMO Open (2023) Vol. 8, Iss. 1, pp. 100774-100774
Open Access | Times Cited: 18
Targeted and Shallow Whole-Genome Sequencing Identifies Therapeutic Opportunities in p53abn Endometrial Cancers
Amy Jamieson, Juliana Sobral de Barros, Dawn R. Cochrane, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 11, pp. 2461-2474
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top